|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00440661 |
|
Date of registration:
|
26/02/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Exploration of the Synovial Fluid Inflammation Mediators Under Diacerhein in Knee Osteoarthritis
|
|
Scientific title:
|
Exploratory Study of Some Synovial Fluid Inflammation Mediatorsunder Diacerhein in Knee Osteoarthritis Patients. Phase IV Study. |
|
Date of first enrolment:
|
March 2007 |
|
Target sample size:
|
96 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00440661 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Canada
| | | | | | | |
|
Contacts
|
|
Name:
|
Jean-Pierre RAYNAULD, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Institut de Rhumatologie de Montreal |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Painful osteoarthritis
- Hydarthrosis (synovial effusion)
Exclusion Criteria:
- large effusion
- severe pathologies
- anti-osteoarthritic treatments
Age minimum:
45 Years
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Osteoarthritis
|
|
Intervention(s)
|
|
Drug: Diacerhein
|
|
Primary Outcome(s)
|
|
Synovial concentration of IL-1
|
|
Secondary Outcome(s)
|
|
Synovial concentration of IL-6
|
|
WOMAC
|
|
Secondary ID(s)
|
|
109196
|
|
HEC/ART06572N
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|